| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |